FBXO32 and muscle atrophy: Studies have reported that the activation of NF-κB can increase the expression of atrogin-1/MAFbx and MuRF1 in muscle atrophy models; NF-κB also inhibits the expression of mitochondrial genes, thereby reducing mitochondrial biosynthesis [18, 19].